chr3-128879626-CGT-C
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_014049.5(ACAD9):c.-57_-56del variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.312 in 1,585,160 control chromosomes in the GnomAD database, including 83,489 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.39 ( 13536 hom., cov: 0)
Exomes 𝑓: 0.30 ( 69953 hom. )
Consequence
ACAD9
NM_014049.5 5_prime_UTR
NM_014049.5 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.290
Genes affected
ACAD9 (HGNC:21497): (acyl-CoA dehydrogenase family member 9) This gene encodes a member of the acyl-CoA dehydrogenase family. Members of this family of proteins localize to the mitochondria and catalyze the rate-limiting step in the beta-oxidation of fatty acyl-CoA. The encoded protein is specifically active toward palmitoyl-CoA and long-chain unsaturated substrates. Mutations in this gene cause acyl-CoA dehydrogenase family member type 9 deficiency. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 3-128879626-CGT-C is Benign according to our data. Variant chr3-128879626-CGT-C is described in ClinVar as [Benign]. Clinvar id is 343189.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.614 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACAD9 | NM_014049.5 | c.-57_-56del | 5_prime_UTR_variant | 1/18 | ENST00000308982.12 | ||
ACAD9 | NM_001410805.1 | c.-332_-331del | 5_prime_UTR_variant | 1/17 | |||
ACAD9 | NR_033426.2 | n.16_17del | non_coding_transcript_exon_variant | 1/18 | |||
ACAD9 | XR_427367.4 | n.16_17del | non_coding_transcript_exon_variant | 1/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACAD9 | ENST00000308982.12 | c.-57_-56del | 5_prime_UTR_variant | 1/18 | 1 | NM_014049.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.393 AC: 59660AN: 151738Hom.: 13513 Cov.: 0
GnomAD3 genomes
AF:
AC:
59660
AN:
151738
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.333 AC: 82499AN: 247442Hom.: 15389 AF XY: 0.326 AC XY: 43880AN XY: 134788
GnomAD3 exomes
AF:
AC:
82499
AN:
247442
Hom.:
AF XY:
AC XY:
43880
AN XY:
134788
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.303 AC: 434806AN: 1433306Hom.: 69953 AF XY: 0.302 AC XY: 215648AN XY: 714612
GnomAD4 exome
AF:
AC:
434806
AN:
1433306
Hom.:
AF XY:
AC XY:
215648
AN XY:
714612
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.393 AC: 59733AN: 151854Hom.: 13536 Cov.: 0 AF XY: 0.388 AC XY: 28789AN XY: 74258
GnomAD4 genome
AF:
AC:
59733
AN:
151854
Hom.:
Cov.:
0
AF XY:
AC XY:
28789
AN XY:
74258
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Acyl-CoA dehydrogenase 9 deficiency Benign:3
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at